Product Information

FONDAPARINUX 5 MG/0.4 ML SYR is a generic product labeled by Eugia US LLC, priced at $55.3125 per ML under NDC 55150023110. Its NADAC has been published 66 times since May 21, 2025.

FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AP.

FONDAPARINUX 5 MG/0.4 ML SYR

FONDAPARINUX SODIUM
$55.3125per ML

Strength

5 mg/.4mL

Manufacturer

Eugia US LLC

NDC

55150023110

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

9/17/2025

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206918

FDA Approved

12/26/2017

TE Code

AP

On Market Since

12/26/2017

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has been published 66 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$55.3125 per ML
All-time high$55.3125 (Aug 19, 2026)
All-time low$55.3125 (May 21, 2025)
52-week high$55.3125
52-week low$55.3125
Median price$55.3125
Average price$55.3125
Largest weekly change0.0% (May 28, 2025)
Weeks tracked66
Tracking sinceMay 21, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of FONDAPARINUX 5 MG/0.4 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 5 MG/0.4 ML SYR, manufactured by Eugia US LLC, is $55.3125 per ML (NDC 55150023110), effective Aug 19, 2026.

How has the price of FONDAPARINUX 5 MG/0.4 ML SYR changed over time?

Over the history we have for it, the NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has held within roughly two percent of its current level. It has been tracked across 66 weekly CMS publications since May 21, 2025.

What are the highest and lowest recorded NADAC prices for FONDAPARINUX 5 MG/0.4 ML SYR?

Since May 21, 2025, the NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has ranged from a low of $55.3125 (May 21, 2025) to a high of $55.3125 (Aug 19, 2026), with a median of $55.3125 per ML.

Are there cheaper alternatives to FONDAPARINUX 5 MG/0.4 ML SYR?

No other NADAC-published product currently shares the active ingredient and strength of FONDAPARINUX 5 MG/0.4 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FONDAPARINUX 5 MG/0.4 ML SYR?

FONDAPARINUX 5 MG/0.4 ML SYR (NDC 55150023110) is labeled by Eugia US LLC, and CMS classifies it as a generic product.